FDA Pushes Faster Post-Approval Study Starts In Drug-Eluting Stent Guidance

FDA's March 26 1draft guidance on nonclinical and clinical studies of drug-eluting coronary stents is the first device guidance to recommend that sponsors begin post-market studies before their device is approved